SEC Form 4 · accession 0001209191-17-017107
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Belsky
Officer — Senior Vice President and CFO
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 1:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2017 | F | 18,881 | $44.77 | D | 46,785 | I | By the Belsky Living Trust |
| Common Stock | holding | — | — | — | 12,656 | D |
Table II — derivative securities
No Table II lines on this filing.